Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04067752 · ClinicalTrials.gov registry record · NA
Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04067752: Completed NA study, sponsored by VA Office of Research and Development.
NCT04067752 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04067752, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
By 2030 an estimated 2 million people in the US will need dialysis or transplantation. Insulin resistance and chronic inflammation are common in dialysis patients and have been linked to protein-energy wasting, the most important determinant of clinical outcome in this patient population. The investigators hypothesize that the skin and muscle tissue sodium accumulation is a critical mechanism by which chronic inflammatory response and insulin resistance, alone or in combination lead to protein energy wasting in hemodialysis patients. The investigators will test this hypothesis by studying dialysis patients and matched controls without kidney disease by examining tissue Na content, markers of inflammation and protein metabolism.
Interventions
- OTHER high dialysate sodium concentration (138 mEq/L)
- OTHER Low dialysate sodium concentration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2024-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04067752
The ClinicalTrials.gov registry entry for NCT04067752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which high dialysate sodium concentration (138 mEq/L) is the first listed.
NCT04067752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04067752 about?
NCT04067752 is a clinical study titled "Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease". By 2030 an estimated 2 million people in the US will need dialysis or transplantation. Insulin resistance and chronic inflammation are common in dialysis patients and have been linked to protein-energy wasting, the most important determinant of clinical outcome in this patient population. The invest...
What is the current status of trial NCT04067752?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-03-01. Estimated completion is 2024-05-20.
What interventions are being tested in trial NCT04067752?
The interventions under investigation include: high dialysate sodium concentration (138 mEq/L) (OTHER), Low dialysate sodium concentration (OTHER).
Who is sponsoring clinical trial NCT04067752?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.